Randomized trial evaluates local versus systemic calcitriol effects on bone regeneration in rabbits, indicating local use may enhance healing.
PURPOSE: This study compared the effects of local and systemic calcitriol administration on bone regeneration in a xenograft-based rabbit maxillary sinus augmentation model. MATERIALS AND METHODS: Eighteen New Zealand rabbits were randomly assigned to three groups (n = 6 per group at baseline): control (xenograft only), local calcitriol (xenograft hydrated with 0.1 µg/kg calcitriol per sinus), and systemic calcitriol (single intravenous dose of 0.2 µg/kg). After 10 weeks, histomorphological scoring, RT-qPCR quantification of VEGF and BMP-2, and serum 25(OH)D measurements were performed. RESULTS: Osteoblast activity was significantly higher in the local calcitriol group than in the control group (p = 0.024). Ossification scores showed a numerical trend toward higher values in the local group but did not reach statistical significance (p = 0.061). VEGF and BMP-2 expression were approximately 17.2-fold and 29.3-fold higher in the local group compared with controls (Bonferroni-corrected p < 0.001 for both); the systemic group showed intermediate expression without reaching corrected significance. Serum 25(OH)D levels showed no significant between-group differences at any time point. CONCLUSIONS: Local calcitriol delivery was associated with significantly greater osteoblast activity and VEGF and BMP-2 expression, along with a non-significant trend toward higher ossification scores. Local application via routine graft hydration may represent a practical, low-cost strategy to enhance bone regeneration without systemic exposure, warranting confirmation in larger clinical studies.
No takes yet. Share an insight, caveat, or question.
Okumuş et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: